News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
142
Sources here
24
Companies here
9
Search results Stored financial headlines

Active search

142 matching headlines

Ticker or company: CORAMain company stories
Clear
Latest

Simply Wall Street Earnings

Do Strong Q3 Results And Bigger Credit Lines Change The Bull Case For Cencora (COR)?

Cencora (COR) recently reported strong Q3 2026 results with $84.75 billion in sales and $763.52 million in net income, alongside declaring a $0.60 quarterly dividend. The company also expanded its multi-currency credit facility to $7.00 billion with maturities extended to 2031, reinforcing its financial flexibility. These developments support Cencora's investment narrative focused on scale in pharmaceutical distribution and …

Cencora (COR): Leveraging Healthcare Growth and AI-Driven Productivity

Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the "Insiders Fund". A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% …

COR main company ABC main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Kincora Reports June 2026 Quarterly Activities and Financial Results

Vancouver, British Columbia--(Newsfile Corp. - August 14, 2026) - Copper-gold explorer and hybrid project generator Kincora Copper Limited (ASX: KCC) (TSXV: KCC) ("Kincora" or "the Company") is pleased to report its financial and operating results for the quarter ended June 30, 2026. During the …

KCC main company
Sharemaestro market context Price below Trend Line 52 weeks +29.9% KCC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call

5 Insightful Analyst Questions From Cencora's Q2 Earnings Call Cencora's second quarter was marked by performance that met Wall Street's expectations on revenue and exceeded consensus on non-GAAP profitability, driving a positive market response. Management credited execution in specialty pharmaceuticals, especially through its Management …

COR main company ABC main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today

Cencora (NYSE: COR) has significantly outperformed the market over the last decade, with an average annual return of 19.83%. An initial investment of $1000 in COR stock ten years ago would now be worth $6,070.40, highlighting the power of compounded returns. The company currently …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora: Walgreens Volume Disruption Raises New Concern, but We Make No Changes for Now

Cencora disclosed that a portion of the volume it serviced for Walgreens began moving elsewhere starting July 1, causing a 4% drop in shares. Despite this new concern, the company reaffirmed its full-year EPS guidance of $17.75-$17.95, and Morningstar analysts are not yet making …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora Inc. stock underperforms Wednesday when compared to competitors

Cencora Inc. (COR) stock fell by 5.90% to $314.17 on Wednesday, underperforming the broader market. This drop occurred despite the S&P 500 Index seeing a slight gain, while the Dow Jones Industrial Average experienced a marginal decline. The stock's fall ended a two-day winning …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora Inc Stock (COR) Closed Down by 5.92% on Aug 12: Key Drivers Unveiled

Cencora Inc (COR) stock closed down by 5.92% on August 12, primarily due to the confirmed transition of non-prime Walgreens pharmaceutical volume to competitors. Despite management reiterating full-year earnings per share guidance, investors focused on potential revenue risks and customer retention challenges in the …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora reaffirms $17.75-$17.95 FY26 EPS guidance amid Walgreens shift

Cencora confirmed that some Walgreens volume will shift outside its operations starting July 1, 2026, but its primary vendor agreement with Walgreens remains unaffected. The company reiterated its fiscal year 2026 adjusted diluted EPS guidance of $17.75-$17.95, stating that this change was already factored …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora Reports Walgreens Volume Transition, Confirms FY2026 Adjusted EPS Forecast

Cencora, Inc. has reported to the SEC that some Walgreens volume began transitioning out of the company on July 1, 2026, a move that was fully anticipated and does not affect their prime vendor agreement with Walgreens. The company reconfirmed its adjusted diluted EPS …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora says certain Walgreens volume moves outside company; reaffirms FY26 adjusted EPS $17.75-$17.95

Cencora announced that certain Walgreens volume began moving outside the company as of July 1, 2026. Despite this change, the prime vendor agreement with Walgreens, which represents the majority of Cencora's Walgreens business, remains unchanged. Cencora reaffirmed its fiscal year 2026 adjusted diluted EPS …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora dips on loss of some Walgreens business (COR:NYSE)

Cencora's shares experienced a decline in afternoon trading after the medical distributor announced the loss of some business operations previously serving the Walgreens pharmacy chain. The company, formerly known as AmerisourceBergen, stated that certain business activities are moving outside their previous arrangement. This development …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora maintains earnings guidance as some Walgreens volume moves away

Cencora (NYSE:COR) announced that some Walgreens volume previously serviced outside of its prime vendor agreement has shifted away, effective July 1. Despite this change, which was anticipated, the company reaffirmed its adjusted diluted earnings per share guidance of $17.75 to $17.95 for fiscal year …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora (COR) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Senior Vice President, Investor Relations and Enterprise Productivity - Bennett Murphy President and Chief Executive Officer - Robert Mauch Executive Vice President and Chief Financial Officer - Eva …

COR main company ABC main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wedge Capital Management L L P NC Increases Position in Cencora, Inc. $COR

Wedge Capital Management L L P NC has increased its stake in Cencora, Inc. (NYSE:COR) by 31.0% during the second quarter, bringing its total holdings to 105,614 shares valued at approximately $29.9 million. Institutional investors and hedge funds collectively own 97.52% of the company's …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insight Wealth Strategies LLC Purchases 6,648 Shares of Cencora, Inc. $COR

Insight Wealth Strategies LLC increased its stake in Cencora, Inc. by 37.6% in the second quarter, adding 6,648 shares. Institutional investors hold 97.52% of the company, and analysts have a "Moderate Buy" consensus with an average price target of $374.25. Cencora also surpassed earnings …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora, Inc. (NYSE:COR) Given Average Rating of "Moderate Buy" by Brokerages

Cencora, Inc. (NYSE:COR) has received a consensus "Moderate Buy" rating from fifteen brokerage firms, with an average 12-month price target of $374.25. The company recently surpassed quarterly earnings expectations, reporting $4.48 in adjusted EPS and $84.75 billion in revenue. Cencora also authorized a $2 …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CENCORA INC. : WELLS FARGO RAISES TARGET PRICE TO $395 FROM $331

Wells Fargo has increased its target price for Cencora Inc. from $331 to $395. This news was reported by Reuters and indicates a positive outlook from the financial institution on Cencora's future performance. The article itself provides minimal detail beyond this price target adjustment.

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora Inc. stock outperforms competitors on strong trading day

Cencora Inc. (COR) stock rose 2.73% to $333.87 on Tuesday, outperforming the broader market which saw the S&P 500 and Dow Jones Industrial Average both decline. This marks the second consecutive day of gains for Cencora.

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora, Inc. $COR Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB significantly reduced its holdings in Cencora, Inc. (NYSE:COR) by 32.4% in the second quarter, selling over 105,000 shares but still retaining a substantial stake. Despite this sale, Cencora demonstrated strong financial performance, exceeding earnings and revenue expectations, and announced a $2 …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora (COR) Posts Strong Q3 Earnings, Is The 9% Upside Enough?

Cencora (COR) recently reported strong Q3 2026 results with increased sales, net income, and EPS, alongside share repurchases and a new dividend. Despite a 22.81% 90-day return, the stock is down 5.43% year-to-date, though its 5-year total shareholder return is 179.97%. Simply Wall St's …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora, Inc. (COR) Stock Forecasts

This article provides a stock forecast for Cencora, Inc. (COR), a major pharmaceutical wholesaler. It highlights a Morningstar report from August 5, 2026, which discusses Cencora's earnings growth and market confidence recovery. The report also positions Cencora among leading domestic pharmaceutical wholesalers.

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

The Bull Case For Cencora (COR) Could Change Following Raised EPS Outlook And Bigger Buybacks And Dividend

Cencora recently announced strong third-quarter 2026 results, including higher sales and net income, alongside an increased adjusted EPS outlook and expanded revolving credit capacity. The company is actively returning capital to shareholders through buybacks and dividends, while also monitoring a potential MWI Animal Health–Covetrus …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cencora Inc. stock underperforms Friday when compared to competitors

Cencora Inc. (COR) shares dropped 1.40% on Friday, closing at $320.46, despite a generally positive trading day for the broader market. This underperformance broke a two-day winning streak for the stock. The S&P 500 Index and the Dow Jones Industrial Average both saw gains …

COR main company
Sharemaestro market context Price below Trend Line 52 weeks +7.9% · Next-week setup positive 58.8% COR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context